Bringing Therapeutic Cancer Vaccines and Immunotherapies Through Development to Licensure (Day 1)

Loading... Loading video...

Air date:	Thursday, February 8, 2007, 8:00:00 AM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 315 * This only includes stats from October 2011 and forward.
Category:	Conferences
Runtime:	08:23:11
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	A variety of promising cancer vaccines and immunotherapies are in the pipeline, but they must travel down a rigorous scientific and licensing pathway. Plan now to attend this workshop, cosponsored by FDA and NCI, to learn from experts in government, industry, and academia about what is needed to bring cancer vaccines and immunotherapies through development and clinical trials to licensure. This workshop is ideal for researchers and representatives of biotechnology and pharmaceutical companies who are involved in product development and preparation for licensure. Individuals and companies will gain important insights into the efficient development of cancer vaccines and how to avoid development pitfalls. The workshop is also an opportunity for industry to provide feedback to regulatory agencies. For more information, visit https://cms.palladianpartners.com/cms/1156354418/home.htm

NLM Title:	Bringing therapeutic cancer vaccines and immunotherapies through development to licensure / NCI and FDA.
Author:	National Cancer Institute (U.S.)
Publisher:
Abstract:	(CIT): A variety of promising cancer vaccines and immunotherapies are in the pipeline, but they must travel down a rigorous scientific and licensing pathway. Plan now to attend this workshop, cosponsored by FDA and NCI, to learn from experts in government, industry, and academia about what is needed to bring cancer vaccines and immunotherapies through development and clinical trials to licensure. This workshop is ideal for researchers and representatives of biotechnology and pharmaceutical companies who are involved in product development and preparation for licensure. Individuals and companies will gain important insights into the efficient development of cancer vaccines and how to avoid development pitfalls. The workshop is also an opportunity for industry to provide feedback to regulatory agencies.
Subjects:	Cancer Vaccines Drug Design Immunotherapy Licensure, Pharmacy Neoplasms--immunology Neoplasms--therapy
Publication Types:	Lecture Webcast
NLM Classification:	QZ 266
NLM ID:	101306041
CIT Live ID:	5542
Permanent link:	https://videocast.nih.gov/watch=5542

NIH VideoCasting